In adult PWS patients we demonstrated a direct link with the age of sex steroid replacement therapy and the age of GH therapy, suggesting the key role of the beginning of the therapy to normalize the levels of the myokine in these subjects. The gene discussed is GH1; the disease is Prader-Willi syndrome.